Dina Sakaeva

4.6k total citations
44 papers, 267 citations indexed

About

Dina Sakaeva is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Dina Sakaeva has authored 44 papers receiving a total of 267 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Oncology, 15 papers in Pulmonary and Respiratory Medicine and 13 papers in Cancer Research. Recurrent topics in Dina Sakaeva's work include Cancer Treatment and Pharmacology (7 papers), Lung Cancer Treatments and Mutations (6 papers) and Colorectal Cancer Treatments and Studies (5 papers). Dina Sakaeva is often cited by papers focused on Cancer Treatment and Pharmacology (7 papers), Lung Cancer Treatments and Mutations (6 papers) and Colorectal Cancer Treatments and Studies (5 papers). Dina Sakaeva collaborates with scholars based in Russia, Spain and France. Dina Sakaeva's co-authors include Р. А. Зуков, Robert D. Loberg, Susan Cottrell, М. В. Копп, Javier Sastre, Ian McCaffery, Joan Maurel, Elżbieta Nowara, Francesco Galimi and Allen Lee Cohn and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer Research.

In The Last Decade

Dina Sakaeva

29 papers receiving 262 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dina Sakaeva Russia 9 165 96 88 48 32 44 267
Sumiko Okubo Japan 10 165 1.0× 116 1.2× 68 0.8× 40 0.8× 24 0.8× 25 296
Tao Osgood United States 6 185 1.1× 158 1.6× 58 0.7× 43 0.9× 20 0.6× 14 308
Marco Brugia Italy 12 218 1.3× 117 1.2× 128 1.5× 100 2.1× 17 0.5× 31 354
Jürgen Wolf Germany 9 95 0.6× 108 1.1× 87 1.0× 50 1.0× 29 0.9× 13 277
Lihou Dong China 9 163 1.0× 86 0.9× 56 0.6× 34 0.7× 61 1.9× 19 294
Guzmán Alonso Spain 8 177 1.1× 66 0.7× 161 1.8× 75 1.6× 18 0.6× 34 313
Fabien Gaire Germany 5 133 0.8× 88 0.9× 54 0.6× 38 0.8× 49 1.5× 11 200
G. Atalay Belgium 7 182 1.1× 63 0.7× 72 0.8× 82 1.7× 50 1.6× 12 317
Davide Bosso Italy 12 132 0.8× 133 1.4× 167 1.9× 70 1.5× 57 1.8× 18 366
Albaha Barqawi United States 5 167 1.0× 107 1.1× 187 2.1× 70 1.5× 59 1.8× 10 351

Countries citing papers authored by Dina Sakaeva

Since Specialization
Citations

This map shows the geographic impact of Dina Sakaeva's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dina Sakaeva with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dina Sakaeva more than expected).

Fields of papers citing papers by Dina Sakaeva

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dina Sakaeva. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dina Sakaeva. The network helps show where Dina Sakaeva may publish in the future.

Co-authorship network of co-authors of Dina Sakaeva

This figure shows the co-authorship network connecting the top 25 collaborators of Dina Sakaeva. A scholar is included among the top collaborators of Dina Sakaeva based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dina Sakaeva. Dina Sakaeva is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fedorova, Yu. Yu., et al.. (2025). Study of the association between HIF1A and VEGFA gene polymorphisms and ovarian cancer risk in women from Bashkortostan. Siberian Journal of Oncology. 24(1). 79–91.
2.
Mingazheva, Elvira, Yu. Yu. Fedorova, Elena Andreeva, et al.. (2024). The role of microRNAs in the pathogenesis of ovarian cancer. Yakut Medical Journal. 85(1). 81–87.
3.
Sakaeva, Dina, et al.. (2023). Whole Exome Sequencing Study Suggests an Impact of FANCA, CDH1 and VEGFA Genes on Diffuse Gastric Cancer Development. Genes. 14(2). 280–280. 1 indexed citations
4.
Sakaeva, Dina, et al.. (2023). The role of molecular genetic changes in the structure of the CDH1 gene in the development of gastric cancer in patients from the Republic of Bashkortostan. Open Access Repository (Belgorod State National Research University). 9(1).
5.
Sakaeva, Dina. (2023). Anemia and iron deficiency in cancer patients: the role of intravenous iron supplements (a literature review). SHILAP Revista de lepidopterología. 24(4). 468–476.
6.
7.
Sakaeva, Dina, et al.. (2022). Off-Label Drug Use in Oncology. SHILAP Revista de lepidopterología. 12(2). 164–171.
8.
Бредер, В. В., Evgeny N. Imyanitov, К. К. Лактионов, et al.. (2022). Resolution on the results of Advisory Board “Searching the effective methods of testing and treating patients with NSCLC caused by <i>NTRK</i> gene fusions“. SHILAP Revista de lepidopterología. 50–56.
9.
Tjulandin, S., Lev Demidov, Vladimir Moiseyenko, et al.. (2021). Novel PD-1 inhibitor prolgolimab: expanding non-resectable/metastatic melanoma therapy choice. European Journal of Cancer. 149. 222–232. 37 indexed citations
10.
Chudakova, Daria A., et al.. (2020). Lynch Syndrome Germline Mutations in Breast Cancer: Next Generation Sequencing Case-Control Study of 1,263 Participants. Frontiers in Oncology. 10. 666–666. 15 indexed citations
11.
Cortés, Javier, Véronique Dièras, Sylvie Lorenzen, et al.. (2020). Efficacy and Safety of Trastuzumab Emtansine Plus Capecitabine vs Trastuzumab Emtansine Alone in Patients With Previously Treated ERBB2 (HER2)-Positive Metastatic Breast Cancer. JAMA Oncology. 6(8). 1203–1203. 35 indexed citations
12.
Sakaeva, Dina, et al.. (2019). Oral chemotherapy with vinorelbine for advanced breast cancer: its role in clinical practice. Фарматека. 7_2019. 96–101. 1 indexed citations
13.
Хусаинова, Р. И., et al.. (2018). Роль генетических факторов в развитии рака желудка. 17(4). 3–15. 1 indexed citations
14.
15.
Sakaeva, Dina. (2017). ALGORITHMS FOR MANAGEMENT OF PATIENTS WITH ADVERSE EVENTS ON THERAPY WITH TYROSINE KINASE INHIBITORS EGFR. Meditsinskiy sovet = Medical Council. 38–50.
16.
LaBonte, Melissa J., Dongyun Yang, Wu Zhang, et al.. (2016). A Phase II Biomarker-Embedded Study of Lapatinib plus Capecitabine as First-line Therapy in Patients with Advanced or Metastatic Gastric Cancer. Molecular Cancer Therapeutics. 15(9). 2251–2258. 8 indexed citations
17.
Sakaeva, Dina, et al.. (2016). 153P: Real-time PCR and digital PCR approach for detecting EGFR status in plasma of patients with NSCLC. Journal of Thoracic Oncology. 11(4). S124–S125. 2 indexed citations
18.
Sakaeva, Dina, et al.. (2015). The immunosuppressive microenvironment of malignant gliomas. Russian Journal of Archive of Pathology. 77(6). 54–54. 14 indexed citations
19.
Cohn, Allen Lee, Josep Tabernero, Joan Maurel, et al.. (2013). A randomized, placebo-controlled phase 2 study of ganitumab or conatumumab in combination with FOLFIRI for second-line treatment of mutant KRAS metastatic colorectal cancer. Annals of Oncology. 24(7). 1777–1785. 74 indexed citations
20.
Pishvaian, Michael J., Dina Sakaeva, Ruey-Kuen Hsieh, et al.. (2011). A global, multicenter phase II trial of lapatinib plus capecitabine in gastric cancer.. Journal of Clinical Oncology. 29(4_suppl). 88–88. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sumiko Okubo Breakdown of academic impact, for papers by Tao Osgood Breakdown of academic impact, for papers by Marco Brugia Breakdown of academic impact, for papers by Jürgen Wolf Breakdown of academic impact, for papers by Lihou Dong Breakdown of academic impact, for papers by Guzmán Alonso Breakdown of academic impact, for papers by Fabien Gaire Breakdown of academic impact, for papers by G. Atalay Breakdown of academic impact, for papers by Davide Bosso Breakdown of academic impact, for papers by Albaha Barqawi
Rankless by CCL
2026